Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients

被引：0
|
作者：
Bari, Shahla [1 ]
Chan, Austin [1 ]
Olanipekun, Titilope [1 ]
Chawla, Saurabh [2 ]
机构：
[1] Morehouse Sch Med, Atlanta, GA 30310 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
888
引用
收藏
页码：S493 / S494
页数：2
相关论文
共 50 条
  • [41] Hepatocellular carcinoma in patient co-infected with HIV, HBV, and HCV
    Ahmed, Ali
    Yen, Roy
    Rani, Abha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S121 - S122
  • [42] Phylogenetic analysis of hepatitis C virus among HIV/HCV co-infected patients in Nigeria
    Shenge, Juliet A.
    Odaibo, Georgina N.
    Olaleye, David O.
    PLOS ONE, 2019, 14 (02):
  • [43] Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review
    Ashwani K Singal
    Bhupinderjit S Anand
    World Journal of Gastroenterology, 2009, 15 (30) : 3713 - 3724
  • [44] Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review
    Singal, Ashwani K.
    Anand, Bhupinderjit S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (30) : 3713 - 3724
  • [45] Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
    Bruno, Giuseppe
    Saracino, Annalisa
    CURRENT HIV RESEARCH, 2017, 15 (06) : 422 - 433
  • [46] Adverse effects in HIV infected patients co-infected with hepatitis C virus (HCV) receiving antiretroviral treatment and the treatment of tuberculosis infection
    Dragovic, J
    Jevtovic, LJD
    DRUG SAFETY, 2004, 27 (12) : 927 - 928
  • [47] Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV
    Paniagua-Garcia, Maria
    Lopez-Hernandez, Inmaculada
    Fernandez-Cuenca, Felipe
    Jose Rios-Villegas, Maria
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (10): : 681 - 682
  • [48] Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients
    Mariné-Barjoan, E
    Saint-Paul, MC
    Pradier, C
    Chaillou, S
    Anty, R
    Michiels, JF
    Sattonnet, C
    Ouzan, D
    Dellamonica, P
    Tran, A
    AIDS, 2004, 18 (16) : 2163 - 2170
  • [49] There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV
    Souza, A. R.
    Tovo, C. V.
    Mattos, A. A.
    Chaves, S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2008, 41 (03) : 223 - 228
  • [50] Treatment of cirrhotic monoinfected and HCV/HIV coinfected patients with direct acting antivirals (DAAs)
    Santos, F. Videira
    Cipriano, A.
    Valdoleiros, S.
    Tavares, A. P.
    Horta, A.
    Mendez, J.
    Vasconcelos, O.
    Seabra, J.
    Abreu, M. A.
    Goncalves, M. J.
    Santos, M. J.
    Sarmento-Castro, R.
    HIV MEDICINE, 2019, 20 : 303 - 304
12345